Literature DB >> 6743621

Inferior rectus paresis after secondary blepharoplasty.

E Alfonso, A J Levada, J T Flynn.   

Abstract

A 52-year-old woman underwent a secondary cosmetic blepharoplasty for repair of residual dermatochalasis. After this procedure vertical diplopia was noted. Ultrasound examination and the findings at operation were consistent with trauma to the inferior rectus muscle. We present this as an additional complication of cosmetic blepharoplasty.

Entities:  

Mesh：

Year:  1984        PMID： 6743621      PMCID： PMC1040408          DOI： 10.1136/bjo.68.8.535

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  4 in total

1.  Complications of blepharoplasty.

Authors:  M R Levine; J Boynton; R R Tenzel; G R Miller
Journal:  Ophthalmic Surg       Date:  1975

2.  Blepharoplasty.

Authors:  M Spira
Journal:  Clin Plast Surg       Date:  1978-01       Impact factor: 2.017

3.  Surgical treatment of complications of cosmetic blepharoplasty.

Authors:  R R Tenzel
Journal:  Clin Plast Surg       Date:  1978-10       Impact factor: 2.017

4.  Superior oblique paresis after blepharoplasty.

Authors:  R E Wesley; Z F Pollard; C D McCord
Journal:  Plast Reconstr Surg       Date:  1980-08       Impact factor: 4.730
  4 in total
  3 in total

1.  Inferior rectus palsy as an isolated ocular motor sign: acquired etiologies and outcome.

Authors:  Kwang-Dong Choi; Jae-Hwan Choi; Hee Young Choi; Young-Eun Huh; Hyo Jung Kim; Sun-Young Oh; Seong-Hae Jeong; Jeong-Min Hwang; Ji Soo Kim
Journal:  J Neurol       Date:  2012-06-29       Impact factor: 4.849

2.  Management of cosmetic eyelid surgery complications.

Authors:  Stephen R Klapper; James R Patrinely
Journal:  Semin Plast Surg       Date:  2007-02       Impact factor: 2.314

3.  Location and Gaze-Dependent Shift of Inferior Oblique Muscle Position: Anatomic Contributors to Vertical Strabismus Following Lower Lid Blepharoplasty?

Authors:  Sun Young Shin; Joseph L Demer
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.